Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist
article
OA: closed
CC0
⤵ 30 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
Chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist reversibly inhibited pituitary-ovarian function in a potential new treatment for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (8)
- [Conservative treatment of endometriosis]. via openalex
- Conservative Treatment of Endometriosis via openalex
- Recent advances in endometriosis via openalex
- W2289796087 via openalex
- W1971592318 via openalex
- W2059221750 via openalex
- W2412441845 via openalex
- W2046015077 via openalex
Cited by (29)
- Weighing up GnRH agonist therapy for endometriosis: outcomes and the treatment paradigm 2025
- Comprehensive endometriosis care: a modern multimodal approach for the treatment of pelvic pain and endometriosis 2024
- Use of Mifepristone to Treat Endometriosis: A Review of Clinical Trials and Trial-Like Studies Conducted in China 2010
- Emerging drugs for endometriosis 2008
- Evolution of medical treatment for endometriosis: back to the roots? 2007
- Endometriosis 2003
- LH-RH analogues: I. Their impact on reproductive medicine 1999
- Endometriose 1998
- Leuprolide Acetate Depot and Hormonal Add-Back in Endometriosis: A 12-Month Study 1998
- Prospective randomized double-blind trial of 3 versus 6 months of nafarelin therapy for endometriosis associated pelvic pain 1995
- Management of Stage III and IV endometriosis: a 10-year experience 1994
- Changing concepts of medical treatment of endometriosis 1993
- Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy 1992
- Endocrine Treatment of Endometriosis 1992
- Time-related effects of gonadotropin-releasing hormone analog treatment in experimentally induced endometriosis in the rat 1991
- Gonadotrophin releasing hormone agonist (buserelin) in the treatment of endometriosis: changes in the extent of the disease and in CA 125 serum levels after 6‐month therapy 1990
- Comparison of Buserelin to Danazol Therapy in Endometriosis 1990
- Basic and clinical aspects of GnRH‐agonists in reproduction 1990
- Buserelin 1990
- Comparison of Buserelin to Danazol Therapy in Endometriosis 1990
- A comparison of nafarelin acetate and danazol in the treatment of endometriosis 1990
- Buserelin versus danazol in the treatment of endometriosis-associated infertility 1989
- GnRH Analogues in the Treatment of Endometriosis 1989
- GnRH agonists—antagonists — clinical applications 1988
- Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis 1988
- Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase 1988
- Endometriosis 1987
- Studies Utilizing a Luteinizing-Hormone-Releasing Hormone Agonist in the Therapy of Endometriosis 1986
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. 1983
Source provenance
- europepmc
- last seen: 2026-08-13T06:15:24.848197+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:10:00.881616+00:00
License: CC0
· commercial use OK